Viromed Medical AG VME
XETR · Germany · Health Services
€5.80+0.65 (+12.62%)
Market open· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
RELLINGEN, GERMANY - September 28, 2026 (NEWMEDIAWIRE) - Viromed Medical AG ("Viromed"; ISIN: DE000A40ZVN7), a medical technology company and pioneer of cold plasma technology, today published its half-year report for 2026. In the first half of 2...
RELLINGEN, GERMANY - September 2, 2026 (NEWMEDIAWIRE) - Viromed Medical AG ("Viromed"; ISIN: DE000A40ZVN7), a medical technology company and pioneer in cold plasma technology, has appointed Prof. Dr. Michael A. Rubhausen to its Medical Advisory B...
RELLINGEN, GERMANY - August 10, 2026 (NEWMEDIAWIRE) - Viromed Medical AG ("Viromed"; ISIN: DE000A3MQR65), a medical technology company and pioneer in cold plasma technology, has entered into several new distribution partnerships for its ViroCAP(R...
RELLINGEN, GERMANY - June 2, 2026 (NEWMEDIAWIRE) - Viromed Medical AG ("Viromed"; ISIN: DE000A40ZVN7), a medical technology company and pioneer in cold plasma technology, announces that the multi-year research into the application of cold atmosphe...
RELLINGEN, GERMANY - May 18, 2026 (NEWMEDIAWIRE) - Viromed Medical AG ("Viromed"; ISIN: DE000A40ZVN7), a medical technology company and pioneer in cold plasma technology, has entered into a global distribution partnership with NEBU-TEC Internatio...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.